Remdesivir
Remdesivir is a broad-spectrum antiviral developed by Gilead Sciences. Remdesivir is a prodrug, and upon entry into cells, it is metabolized into the nuceotide triphosphate GS-441524. Remdesivir was investigated for activity for Ebola virus, but it was...